BUY Gabriel India Limited — Madhu Bansal
byMadhu BansalHorizon: NA (inferred Swing (≤2wk))28 Oct 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·28 Oct · today
Gabriel India has successfully incorporated the joint venture company, Faurecia Anand Seating India Private Limited, with an initial investment of approximately INR 10 crores for a 50% stake.
BSE · Company Update·19 Oct · 1w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·4 Aug · 3mo ago
Q2 FY27 results scheduled — board meets 30 Oct 2026
NSE · Board Meeting·In 1 day
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gabriel India
- BUY — Ansh Jogendra Bhilwar26 Oct 2026 · Same day · target ₹1,447 · Expired
- BUY — Muthu Selvaraj, Sharekhan19 Oct 2026 · ~2 weeks · target ₹1,690 · SL hit
- BUY — Prakash Gaba19 Oct 2026 · ~2 weeks · target ₹1,600 · SL hit
- BUY — Prakash Gaba19 Oct 2026 · ~2 weeks · target ₹1,625 · SL hit
- BUY — Sandeep Jain, Tradeswift12 Oct 2026 · ~2 weeks · target ₹1,470 · Target hit
More from Madhu Bansal
- BUY Divi's Laboratories28 Oct 2026 · ~2 weeks · target ₹10,360 · Active
- BUY The Indian Hotels Company26 Oct 2026 · ~2 weeks · target ₹857 · Active
- BUY Garware Hi-Tech Films26 Oct 2026 · ~2 weeks · target ₹7,750 · Active
- BUY Supriya Lifescience29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY Supreme Petrochem29 Sept 2026 · ~2 weeks · target ₹957 · SL hit

